ITIH5 antibody (C-Term)
Quick Overview for ITIH5 antibody (C-Term) (ABIN952964)
Target
See all ITIH5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 578-606, C-Term
-
Specificity
- This antibody recognizes Human ITIH5 (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 578-606 amino acids from the C-terminal region of human ITIH5.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ITIH5 (Inter alpha Globulin Inhibitor H5 (ITIH5))
-
Alternative Name
- ITIH5
-
Background
- This gene encodes a heavy chain component of one of the inter-alpha-trypsin inhibitor (ITI) family members. ITI proteins are involved in extracellular matrix stabilization and in the prevention of tumor metastasis. They are also structurally related plasma serine protease inhibitors and are composed of a light chain and varying numbers of heavy chains. This family member is thought to function as a tumor suppressor in breast and thyroid cancers. Alternative splicing results in multiple transcript variants.Synonyms: Inter-alpha-trypsin inhibitor heavy chain H5, KIAA1953
-
Molecular Weight
- 104576 Da
-
Gene ID
- 80760
-
NCBI Accession
- NP_001001851
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-